Research ArticleArticle
Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination
Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon and Larry M. Karnitz
Molecular Pharmacology October 2012, 82 (4) 767-776; DOI: https://doi.org/10.1124/mol.112.080614
Amelia M. Huehls
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
Jill M. Wagner
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
Catherine J. Huntoon
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
Larry M. Karnitz
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
BRCA1/2 and Rad51 Protect from Floxuridine and ABT-888
Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon and Larry M. Karnitz
Molecular Pharmacology October 1, 2012, 82 (4) 767-776; DOI: https://doi.org/10.1124/mol.112.080614
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement